Hip implant sales continued despite FDA rejection
Johnson & Johnson's DePuy medical device division reportedly sold a model of an artificial metal-on-metal hip overseas even though the Food and Drug Administration had rejected its sale in the United States. The hip replacement joint has since been recalled worldwide.
Knowledgeable lawyers in California and elsewhere know those sales weren't illegal, but they also know that the decision to go ahead with them despite the F.D.A.'s rejection potentially exposes the company to deeper legal and financial troubles from individuals with legitimate personal injury claims.
Continue reading Hip implant sales continued despite FDA rejection
Comments: Leave a comment









